These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 31490236)
1. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors. Dermawan JKT; Farver CF Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236 [TBL] [Abstract][Full Text] [Related]
2. The Prognostic Significance of the 8th Edition TNM Staging of Pulmonary Carcinoid Tumors: A Single Institution Study With Long-term Follow-up. Dermawan JK; Farver CF Am J Surg Pathol; 2019 Sep; 43(9):1291-1296. PubMed ID: 31094922 [TBL] [Abstract][Full Text] [Related]
3. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors. Walts AE; Ines D; Marchevsky AM Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865 [TBL] [Abstract][Full Text] [Related]
4. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung. Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326 [TBL] [Abstract][Full Text] [Related]
5. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids. Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763 [TBL] [Abstract][Full Text] [Related]
6. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors]. Correia Sda S; Pinto C; Bernardo J Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291 [TBL] [Abstract][Full Text] [Related]
7. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence. Marchevsky AM; Hendifar A; Walts AE Mod Pathol; 2018 Oct; 31(10):1523-1531. PubMed ID: 29802361 [TBL] [Abstract][Full Text] [Related]
8. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity. Laitinen KL; Soini Y; Mattila J; Pääkkö P Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours. Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218 [TBL] [Abstract][Full Text] [Related]
10. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P; J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555 [TBL] [Abstract][Full Text] [Related]
11. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Rugge M; Fassan M; Clemente R; Rizzardi G; Giacomelli L; Pennelli G; Mescoli C; Segat D; Rea F Clin Cancer Res; 2008 Jan; 14(1):149-54. PubMed ID: 18172265 [TBL] [Abstract][Full Text] [Related]
12. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung. Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848 [TBL] [Abstract][Full Text] [Related]
13. Histomorphometric evaluation of the Ki-67 proliferation rate and CD34 microvascular and D2-40 lymphovascular densities drives the pulmonary typical carcinoid outcome. de Vilhena AF; das Neves Pereira JC; Parra ER; Balancin ML; Ab Saber A; Martins V; Farhat C; Abrantes MM; de Campos JRM; Tedde ML; Takagaki T; Capelozzi VL Hum Pathol; 2018 Nov; 81():201-210. PubMed ID: 30031097 [TBL] [Abstract][Full Text] [Related]
14. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors. Dhall D; Mertens R; Bresee C; Parakh R; Wang HL; Li M; Dhall G; Colquhoun SD; Ines D; Chung F; Yu R; Nissen NN; Wolin E Hum Pathol; 2012 Apr; 43(4):489-95. PubMed ID: 21937080 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology. Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496 [TBL] [Abstract][Full Text] [Related]
18. Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung. Altinay S; Metovic J; Massa F; Gatti G; Cassoni P; Scagliotti GV; Volante M; Papotti M Virchows Arch; 2019 Sep; 475(3):325-334. PubMed ID: 31201506 [TBL] [Abstract][Full Text] [Related]